https://www.selleckchem.com/pr....oducts/lenalidomide-
AYA patients had increased toxicities in almost every organ system as compared with older children. Conclusions In this large multicenter US database study, we found an overall increased number of toxicities among AYA patients with ALL in children's hospitals. Compared with children between the ages of 10 and 15, AYA patients developed disproportionately higher toxicities from drugs commonly used in pediatric protocols for ALL. Prospective studies are needed to assess whether dose modifications for certain chemotherapeutics m